• Our Company
    • About Us
    • Our Strategic Priorities
    • Our Team
    • Corporate Governance
  • Xanamem®
    • The Cortisol Hypothesis
    • Mechanism of Action
    • Publications
  • Clinical Development
    • Clinical Development Pipeline
      • Alzheimer’s Disease
      • Major Depressive Disorder
      • Fragile X Syndrome
    • Patient Portal
    • Publications
  • Investor Centre
    • Share Price
    • Results Centre
    • ASX Announcements
    • Corporate Presentations
    • Analyst Reports
    • Annual General Meeting
    • General Meeting
    • Financial Calendar
    • Frequently Asked Questions
    • Investor Contacts
  • News
  • Contact Us